Data for PFS of EGFR mutation-positive (EGFR M+) lung cancer were available from 3 trials [7], [22], [25] and data for OS of EGFR M+ lung cancer were available from 2 trials [7], [22]. This evidence concerns the gene EGFR and lung carcinoma.